{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:53:23Z","timestamp":1790970803277,"version":"4.1.0"},"reference-count":62,"publisher":"The Society for Free Radical Research Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2025]]},"DOI":"10.3164\/jcbn.24-219","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T22:12:17Z","timestamp":1738793537000},"page":"280-288","source":"Crossref","is-referenced-by-count":3,"title":["Partially hydrolyzed guar gum ingestion suppresses atopic dermatitis-like symptoms through prebiotic effect in mice"],"prefix":"10.3164","volume":"76","author":[{"given":"So","family":"Morishima","sequence":"first","affiliation":[{"name":"Laboratory of Food Function, Department of Life Sciences, Graduate School of Bioresources, Mie University"},{"name":"Nutrition Division, Taiyo Kagaku Co. Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Abe","sequence":"additional","affiliation":[{"name":"Nutrition Division, Taiyo Kagaku Co. Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Nutrition Division, Taiyo Kagaku Co. Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra P.","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Nutrition Division, Taiyo Kagaku Co. Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Laboratory of Nutritional Chemistry, Department of Life Sciences, Graduate School of Bioresources, Mie University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kuriya","sequence":"additional","affiliation":[{"name":"Laboratory of Nutritional Chemistry, Department of Life Sciences, Graduate School of Bioresources, Mie University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ozeki","sequence":"additional","affiliation":[{"name":"Laboratory of Food Function, Department of Life Sciences, Graduate School of Bioresources, Mie University"},{"name":"Nutrition Division, Taiyo Kagaku Co. Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishio","sequence":"additional","affiliation":[{"name":"Laboratory of Nutritional Chemistry, Department of Life Sciences, Graduate School of Bioresources, Mie University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Miura","sequence":"additional","affiliation":[{"name":"Laboratory of Animal Science, Department of Applied Biological Sciences, Faculty of Agriculture, Setsunan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Inoue","sequence":"additional","affiliation":[{"name":"Laboratory of Animal Science, Department of Applied Biological Sciences, Faculty of Agriculture, Setsunan University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Goh MS, Yun JS, Su JC. Management of atopic dermatitis: a narrative review. Med J Aust 2022; 216: 587\u2013593.","DOI":"10.5694\/mja2.51560"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Bieber T. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discov 2022; 21: 21\u201340.","DOI":"10.1038\/s41573-021-00266-6"},{"key":"3","unstructured":"3 Frazier W, Bhardwaj N. Atopic dermatitis: diagnosis and treatment. Am Fam Physician 2020; 101: 590\u2013598."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ratchataswan T, Banzon TM, Thyssen JP, Weidinger S, Guttman-Yassky E, Phipatanakul W. Biologics for treatment of atopic dermatitis: current status and future prospect. J Allergy Clin Immunol Pract 2021; 9: 1053\u20131065.","DOI":"10.1016\/j.jaip.2020.11.034"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Gatmaitan JG, Lee JH. Challenges and future trends in atopic dermatitis. Int J Mol Sci 2023; 24: 11380.","DOI":"10.3390\/ijms241411380"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Park DH, Kim JW, Park HJ, Hahm DH. Comparative analysis of the microbiome across the gut-skin axis in atopic dermatitis. Int J Mol Sci 2021; 22: 4228.","DOI":"10.3390\/ijms22084228"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Wiertsema SP, van Bergenhenegouwen J, Garssen J, Knippels LMJ. The interplay between the gut microbiome and the immune system in the context of infectious diseases throughout life and the role of nutrition in optimizing treatment strategies. Nutrients 2021; 13: 886.","DOI":"10.3390\/nu13030886"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kim CH. Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity. Cell Mol Immunol 2023; 20: 341\u2013350.","DOI":"10.1038\/s41423-023-00987-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Inoue R, Nishio A, Fukushima Y, Ushida K. Oral treatment with probiotic <i>Lactobacillus johnsonii<\/i> NCC533 (La1) for a specific part of the weaning period prevents the development of atopic dermatitis induced after maturation in model mice, NC\/Nga. Br J Dermatol 2007; 156: 499\u2013509.","DOI":"10.1111\/j.1365-2133.2006.07695.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Fang Z, Li L, Zhang H, Zhao J, Lu W, Chen W. Gut microbiota, probiotics, and their interactions in prevention and treatment of atopic dermatitis: a review. Front Immunol 2021; 12: 720393.","DOI":"10.3389\/fimmu.2021.720393"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Chen S, Tang L, Nie T, Fang M, Cao X. Fructo-oligofructose ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions and psychiatric comorbidities in mice. J Sci Food Agric 2023; 103: 5004\u20135018.","DOI":"10.1002\/jsfa.12582"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Rusu E, Enache G, Cursaru R, et al. Prebiotics and probiotics in atopic dermatitis. Exp Ther Med 2019; 18: 926\u2013931.","DOI":"10.3892\/etm.2019.7678"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 He J, Zhang P, Shen L, et al. Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism. Int J Mol Sci 2020; 21: 6356.","DOI":"10.3390\/ijms21176356"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Coppola S, Avagliano C, Sacchi A, et al. Potential clinical applications of the postbiotic butyrate in human skin diseases. Molecules 2022; 27: 1849.","DOI":"10.3390\/molecules27061849"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Chen G, Ran X, Li B, et al. Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine 2018; 30: 317\u2013325.","DOI":"10.1016\/j.ebiom.2018.03.030"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Hu C, Zeng D, Huang Y, et al. Sodium butyrate ameliorates atopic dermatitis-induced inflammation by inhibiting HDAC3-Mediated STAT1 and NF-\u03baB pathway. Inflammation 2024; 47: 989\u20131001.","DOI":"10.1007\/s10753-023-01955-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Barman M, Gio-Batta M, Andrieux L, et al. Short-chain fatty acids (SCFA) in infants\u2019 plasma and corresponding mother\u2019s milk and plasma in relation to subsequent sensitisation and atopic disease. EBioMedicine 2024; 101: 104999.","DOI":"10.1016\/j.ebiom.2024.104999"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Nylund L, Nermes M, Isolauri E, Salminen S, de Vos WM, Satokari R. Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria. Allergy 2015; 70: 241\u2013244.","DOI":"10.1111\/all.12549"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Slavin JL, Greenberg NA. Partially hydrolyzed guar gum: clinical nutrition uses. Nutrition 2003; 19: 549\u2013552.","DOI":"10.1016\/S0899-9007(02)01032-8"},{"key":"20","unstructured":"20 Sakai S, Kamada Y, Takano H, et al. Continuous partially hydrolyzed guar gum intake reduces cold-like symptoms: a randomized, placebo-controlled, double-blinded trial in healthy adults. Eur Rev Med Pharmacol Sci 2022; 26: 5154\u20135163."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Matsumiya Y, Kapoor MP, Yamaguchi A, Abe A, Sato N. Synergistic effect of partially hydrolyzed guar gum on Clostridium butyricum in a synbiotic combination for enhanced butyrate production during in-vitro fermentation. Funct Foods Health Dis 2024; 14: 455\u2013469.","DOI":"10.31989\/ffhd.v14i7.1385"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kapoor MP, Yamaguchi H, Ishida H, Mizutani Y, Timm D, Abe A. The effects of prebiotic partially hydrolyzed guar gum on skin hydration: a randomized, open-label, parallel, controlled study in healthy humans. J Funct Foods 2023; 103: 105494.","DOI":"10.1016\/j.jff.2023.105494"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Kapoor MP, Abe A, Morishima S, Nakajima A, Ozeki M, Sato N. Dietary intervention of prebiotic partially hydrolyzed guar gum improves skin viscoelasticity, stratum corneum hydration, and reduction of trans-epidermal water loss: a randomized, double-blind, and placebo-controlled clinical study in healthy humans. J Clin Biochem Nutr 2025; 76: 96\u2013115.","DOI":"10.3164\/jcbn.24-69"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Trompette A, Pernot J, Perdijk O, Alqahtani RAA, Domingo JS, Camacho-Mu\u00f1oz D, et al. Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation. Mucosal Immunol 2022; 15: 908\u2013926.","DOI":"10.1038\/s41385-022-00524-9"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Kim JA, Kim SH, Kim IS, et al. Galectin-9 induced by dietary prebiotics regulates immunomodulation to reduce atopic dermatitis symptoms in 1-Chloro-2,4-Dinitrobenzene (DNCB)-treated NC\/Nga mice. J Microbiol Biotechnol 2020; 30: 1343\u20131354.","DOI":"10.4014\/jmb.2005.05017"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Yang CC, Hung YL, Ko WC, et al. Effect of neferine on DNCB-induced atopic dermatitis in HaCaT cells and BALB\/c mice. Int J Mol Sci 2021; 22: 8237.","DOI":"10.3390\/ijms22158237"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Riedl R, K\u00fchn A, Rietz D, et al. Establishment and characterization of mild atopic dermatitis in the DNCB-induced mouse model. Int J Mol Sci 2023; 24: 12325.","DOI":"10.3390\/ijms241512325"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Takayama S, Katada K, Takagi T, et al. Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis. World J Gastroenterol 2021; 27: 2160\u20132176.","DOI":"10.3748\/wjg.v27.i18.2160"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Naito Y, Takagi T, Katada K, et al. Partially hydrolyzed guar gum down-regulates colonic inflammatory response in dextran sulfate sodium-induced colitis in mice. J Nutr Biochem 2006; 17: 402\u2013409.","DOI":"10.1016\/j.jnutbio.2005.08.010"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Takahashi N, Arai I, Honma Y, et al. Scratching behavior in spontaneous- or allergic contact-induced dermatitis in NC\/Nga mice. Exp Dermatol 2005; 14: 830\u2013837.","DOI":"10.1111\/j.1600-0625.2005.00361.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 2018; 34: i884\u2013i890.","DOI":"10.1093\/bioinformatics\/bty560"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Tamames J, Puente-S\u00e1nchez F. SqueezeMeta, A highly portable, fully automatic metagenomic analysis pipeline. Front Microbiol 2019; 9: 3349.","DOI":"10.3389\/fmicb.2018.03349"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Li D, Luo R, Liu CM, et al. MEGAHIT v1.0: a fast and scalable metagenome assembler driven by advanced methodologies and community practices. Methods San Diego Calif 2016; 102: 3\u201311.","DOI":"10.1016\/j.ymeth.2016.02.020"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Morishima S, Abe A, Okamoto S, et al. Partially hydrolyzed guar gum suppresses binge alcohol-induced liver fat accumulation via gut environment modulation in mice. J Gastroenterol Hepatol 2024; 39: 2700\u20132708.","DOI":"10.1111\/jgh.16737"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Shibuya H, Kobayashi H, Kusakabe I. Galactose depletion by <i>Mortierella vinacea<\/i> \u03b1-galactosidase II increases the synergistic interaction between guar gum and xanthan gum. Food Sci Technol Res 1999; 5: 271\u2013272.","DOI":"10.3136\/fstr.5.271"},{"key":"36","unstructured":"36 Naganagouda K, Salimath PV, Mulimani VH. Purification and characterization of endo-\u03b2-1,4 mannanase from <i>Aspergillus niger gr<\/i> for application in food processing industry. J Microbiol Biotechnol 2009; 19: 1184\u20131190."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Jin H, He R, Oyoshi M, Geha RS. Animal models of atopic dermatitis. J Invest Dermatol 2009; 129: 31\u201340.","DOI":"10.1038\/jid.2008.106"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Gilhar A, Reich K, Keren A, Kabashima K, Steinhoff M, Paus R. Mouse models of atopic dermatitis: a critical reappraisal. Exp Dermatol 2021; 30: 319\u2013336.","DOI":"10.1111\/exd.14270"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Saeki H, Iizuka H, Mori Y, et al. Prevalence of atopic dermatitis in Japanese elementary schoolchildren. Br J Dermatol 2005; 152: 110\u2013114.","DOI":"10.1111\/j.1365-2133.2004.06271.x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Saeki H, Oiso N, Honma M, Iizuka H, Kawada A, Tamaki K. Prevalence of atopic dermatitis in Japanese adults and community validation of the U.K. diagnostic criteria. J Dermatol Sci 2009; 55: 140\u2013141.","DOI":"10.1016\/j.jdermsci.2009.04.004"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Wang Y, Zhang P, Zhang J, Hong T. Inhibitory Effect of bisdemethoxycurcumin on DNCB-induced atopic dermatitis in mice. Molecules 2022; 28: 293.","DOI":"10.3390\/molecules28010293"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Liu T, He Y, Liao Y. Esculentoside A ameliorates DNCB-induced atopic dermatitis by suppressing the ROS-NLRP3 axis via activating the Nrf2 pathway. Clin Exp Pharmacol Physiol 2023; 50: 844\u2013854.","DOI":"10.1111\/1440-1681.13809"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Pappa G, Sgouros D, Theodoropoulos K, et al. The IL-4\/-13 axis and its blocking in the treatment of atopic dermatitis. J Clin Med 2022; 11: 5633.","DOI":"10.3390\/jcm11195633"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Seegr\u00e4ber M, Srour J, Walter A, Knop M, Wollenberg A. Dupilumab for treatment of atopic dermatitis. Expert Rev Clin Pharmacol 2018; 11: 467\u2013474.","DOI":"10.1080\/17512433.2018.1449642"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Chiricozzi A, Maurelli M, Peris K, Girolomoni G. Targeting IL-4 for the treatment of atopic dermatitis. Immunotargets Ther 2020; 9: 151\u2013156.","DOI":"10.2147\/ITT.S260370"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Liu FT, Goodarzi H, Chen HY. IgE, mast cells, and eosinophils in atopic dermatitis. Clin Rev Allergy Immunol 2011; 41: 298\u2013310.","DOI":"10.1007\/s12016-011-8252-4"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Esnault S, Benbernou N, Lavaud F, Shin HC, Potron G, Guenounou M. Differential spontaneous expression of mRNA for IL-4, IL-10, IL-13, IL-2 and interferon-gamma (IFN-\u03b3) in peripheral blood mononuclear cells (PBMC) from atopic patients. Clin Exp Immunol 1996; 103: 111\u2013118.","DOI":"10.1046\/j.1365-2249.1996.00911.x"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Schmidt-Weber CB, Alexander SI, Henault LE, James L, Lichtman AH. IL-4 enhances IL-10 gene expression in murine Th2 cells in the absence of TCR engagement. J Immunol 1999; 162: 238\u2013244.","DOI":"10.4049\/jimmunol.162.1.238"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Liu H, Wang J, He T, et al. Butyrate: a double-edged sword for health? Adv Nutr Bethesda Md 2018; 9: 21\u201329.","DOI":"10.1093\/advances\/nmx009"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Kim WK, Jang YJ, Han DH, et al. Administration of <i>Lactobacillus fermentum<\/i> KBL375 causes taxonomic and functional changes in gut microbiota leading to improvement of atopic dermatitis. Front Mol Biosci 2019; 6: 92.","DOI":"10.3389\/fmolb.2019.00092"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Tang L, Cao X, Chen S, Jiang X, Li D, Chen G. Dietary galacto-oligosaccharides ameliorate atopic dermatitis-like skin inflammation and behavioral deficits by modulating gut microbiota\u2013brain\u2013skin axis. J Agric Food Chem 2024; 72: 7954\u20137968.","DOI":"10.1021\/acs.jafc.4c00205"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Yip W, Hughes MR, Li Y, et al. Butyrate shapes immune cell fate and function in allergic asthma. Front Immunol 2021; 12: 628453.","DOI":"10.3389\/fimmu.2021.628453"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012; 489: 231\u2013241.","DOI":"10.1038\/nature11551"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Hung TV, Suzuki T. Dietary fermentable fibers attenuate chronic kidney disease in mice by protecting the intestinal barrier. J Nutr 2018; 148: 552\u2013561.","DOI":"10.1093\/jn\/nxy008"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Matsumoto K, Sawano H, Otsubo M, Yui A. Comparison of the effects of 3 forms of soluble dietary fiber on the production of IgA in BALB\/cAJcl and BALB\/cAJcl-nu\/nu mice. J Nutr 2023; 153: 1618\u20131626.","DOI":"10.1016\/j.tjnut.2023.03.037"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Paparo L, Nocerino R, Ciaglia E, et al. Butyrate as a bioactive human milk protective component against food allergy. Allergy 2021; 76: 1398\u20131415.","DOI":"10.1111\/all.14625"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 F\u00f6h B, Buhre JS, Lunding HB, et al. Microbial metabolite butyrate promotes induction of IL-10+IgM+ plasma cells. PLoS One 2022; 17: e0266071.","DOI":"10.1371\/journal.pone.0266071"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Kim DS, Woo JS, Min HK, et al. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sj\u00f6gren\u2019s syndrome. J Autoimmun 2021; 119: 102611.","DOI":"10.1016\/j.jaut.2021.102611"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Wang J, Cui M, Sun F, et al. HDAC inhibitor sodium butyrate prevents allergic rhinitis and alters lncRNA and mRNA expression profiles in the nasal mucosa of mice. Int J Mol Med 2020; 45: 1150\u20131162.","DOI":"10.3892\/ijmm.2020.4489"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Lee C, Kim BG, Kim JH, Chun J, Im JP, Kim JS. Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner. Int Immunopharmacol 2017; 51: 47\u201356.","DOI":"10.1016\/j.intimp.2017.07.023"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 2016; 165: 1332\u20131345.","DOI":"10.1016\/j.cell.2016.05.041"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Whisner CM, Martin BR, Nakatsu CH, et al. Soluble corn fiber increases calcium absorption associated with shifts in the gut microbiome: a randomized dose-response trial in free-living pubertal females. J Nutr 2016; 146: 1298\u20131306.","DOI":"10.3945\/jn.115.227256"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/76\/3\/76_24-219\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T03:31:03Z","timestamp":1746243063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/76\/3\/76_24-219\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.24-219","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"24-219"}}